Management of Severe Coronary Atherosclerosis Identified on CT Chest

1. Initial Clinical Actions

Patients with CT‑detected severe coronary atherosclerosis should receive immediate cardiology consultation, be scheduled for invasive coronary angiography (ICA) when indicated, and start aggressive medical therapy—including high‑intensity statin, antiplatelet agent, and comprehensive risk‑factor modification. [American College of Radiology] 1, 2, 3

2. Decision‑Making According to CAD‑RADS Severity

2.1 CAD‑RADS 3 (50‑69 % stenosis)

Functional assessment (CT‑FFR, CT perfusion, or stress testing such as exercise ECG, stress echo, SPECT, PET, or cardiac MRI) is recommended to document ischemia, particularly if symptoms persist despite optimal medical therapy. [American College of Radiology] 1, 3, 4

2.2 CAD‑RADS 4A (70‑99 % stenosis in 1‑2 vessels)

Proceed to ICA or functional assessment; ICA is strongly favored when stenosis exceeds 90 %, high‑risk plaque features are present, or the patient has persistent angina despite optimal therapy. [American College of Radiology] 1, 3, 4

2.3 CAD‑RADS 4B (≥50 % left‑main stenosis or ≥70 % three‑vessel disease)

ICA with consideration of revascularization is advised, especially for patients with frequent symptoms despite optimal medical therapy. [American College of Radiology] 1, 3, 4

2.4 CAD‑RADS 5 (total occlusion)

ICA is recommended for definitive evaluation and potential intervention. [American College of Radiology, American College of Cardiology] 1, 2, 3

3. Timing of Cardiology Consultation

Urgent (same‑day or next‑day) cardiology consultation is required for CAD‑RADS 4B or 5, or any severe stenosis with ongoing symptoms. [American College of Radiology] 1, 3

Prompt outpatient cardiology referral is appropriate for CAD‑RADS 3 or 4A in clinically stable patients. [American College of Radiology] 1, 3

4. Evidence‑Based Medical Therapy

4.1 Lipid Management

Initiate high‑intensity statin therapy (e.g., atorvastatin 40‑80 mg or rosuvastatin 20‑40 mg daily) and aim for LDL‑C < 70 mg/dL in high‑risk patients and < 55 mg/dL in very high‑risk patients. [European Society of Cardiology] 5

4.2 Blood‑Pressure Control

Target office systolic BP 120‑130 mmHg for the general adult population and 130‑140 mmHg for patients > 65 years; preferentially use ACE inhibitors or ARBs, especially in the presence of diabetes. [European Society of Cardiology] 5

4.3 Diabetes Management (when applicable)

Optimize glycaemic control (HbA1c targets per guideline) and consider adding SGLT2 inhibitors (e.g., empagliflozin, canagliflozin, dapagliflozin) or GLP‑1 receptor agonists (e.g., liraglutide, semaglutide) for cardiovascular benefit. [European Society of Cardiology] 5

4.4 Lifestyle Modifications

Mandatory smoking cessation, weight management, and regular physical activity are essential components of secondary prevention. [European Society of Cardiology] 5

5. Anti‑Anginal Pharmacotherapy

Beta‑blockers are first‑line agents for symptom control in patients with angina. [American College of Radiology] 4

Ranolazine may be added when anginal symptoms persist despite optimal therapy. [American College of Radiology] 4

6. Key Pitfalls to Avoid

Do not rely solely on anatomic stenosis severity; functional significance may differ (e.g., a 70 % lesion may be non‑ischemic, while a 50 % lesion with high‑risk plaque may be hemodynamically significant). [American College of Radiology] 4

Do not ignore non‑obstructive disease (CAD‑RADS 1‑2) when extensive plaque burden is present; aggressive preventive therapy is warranted. [American College of Cardiology, American College of Radiology] 2, 3

Do not overlook poor image quality (CAD‑RADS N); additional or alternative imaging is required when scans are non‑diagnostic. [American College of Radiology] 1, 3

Do not miss non‑atherosclerotic etiologies (e.g., spontaneous coronary artery dissection, coronary anomalies, vasculitis); these require disease‑specific management. [American College of Radiology] 1

7. Indications for Revascularization

Revascularization (PCI or CABG) should be considered only in patients with:

The primary benefit of revascularization is symptom relief; it is not indicated solely for prognostic improvement in stable patients without significant ischemia. [American College of Radiology] 1, 3, 4

8. Follow‑Up Imaging

Routine repeat coronary CTA is not recommended for patients with established CAD; follow‑up should focus on clinical assessment and non‑invasive functional testing as needed. [European Society of Cardiology] 6

Management of Coronary Lesions Detected on CT Coronary Angiography

Need for Additional Imaging After CTA

• The American College of Cardiology recommends that coronary lesions detected on CT coronary angiography require additional imaging based on the CAD-RADS classification, stenosis severity, and clinical presentation, following a systematic algorithm based on the CAD-RADS 2.0 guidelines 7, 8, 9
• For CAD-RADS 0-2 (0-49% stenosis), no additional imaging is typically required, but consider preventive therapy and risk factor modification, as suggested by the American College of Radiology 7, 8
• For CAD-RADS 3 (50-69% stenosis), consider functional assessment with CT-FFR, CTP, or stress testing to document or exclude ischemia, especially if the patient has persistent symptoms despite medical therapy, according to the American College of Cardiology 7, 9
• For CAD-RADS 4A (70-99% stenosis in 1-2 vessels), further evaluation with invasive coronary angiography or functional imaging is usually recommended, depending on lesion location, extent, severity, and clinical characteristics, as recommended by the American College of Cardiology 7, 9
• For CAD-RADS 4B (Left main stenosis ≥50% or 3-vessel disease >70%), further evaluation with ICA and possible revascularization is usually recommended, particularly for patients with frequent symptoms despite optimal medical therapy, according to the American College of Cardiology 7, 9, 10
• For CAD-RADS 5 (Total occlusion), consider ICA for definitive evaluation and potential intervention, as suggested by the American College of Radiology 8, 9

Factors Influencing Need for Additional Imaging

• The decision for additional imaging should consider stenosis severity, with very high-grade stenosis (>90%) typically warranting ICA, according to the American College of Cardiology 7, 10
• Clinical presentation, such as persistent anginal symptoms despite medical therapy, should favor ICA, as recommended by the American College of Cardiology 7, 10
• Evidence of ischemia, such as presence of lesion-specific ischemia on CT-FFR or perfusion defects by myocardial CTP, may favor ICA, according to the American College of Cardiology 7, 9

Special Considerations

• In cases of suspected spontaneous coronary artery dissection (SCAD), additional imaging with ICA and possibly OCT/IVUS may be needed for definitive diagnosis, as recommended by the American Heart Association 11, 12

Imaging Modality Selection

• CT-derived FFR (CT-FFR) can provide non-invasive assessment of lesion-specific ischemia without additional testing, according to the American College of Cardiology 7, 10
• Stress testing options, such as exercise ECG, stress echocardiogram, SPECT, PET, or cardiac MRI, can provide functional assessment of stenosis significance, as recommended by the European Society of Cardiology 7, 13
• Invasive coronary angiography provides definitive assessment of coronary anatomy and allows for intervention, particularly valuable for high-grade stenosis or when revascularization is being considered, according to the American College of Cardiology 7, 9

Pitfalls to Avoid

• Overreliance on stenosis severity alone should be avoided, as functional significance of stenosis does not always correlate with anatomic severity, according to the American College of Cardiology 7, 10
• Inadequate image quality, such as non-diagnostic studies (CAD-RADS N), requires additional or alternative evaluation, as recommended by the American College of Radiology 8
• Missing non-atherosclerotic causes, such as spontaneous coronary artery dissection, should be considered, and may require specific management approaches, according to the American Heart Association 11, 12